Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liver disease
Pharma
Mirum gets 2nd indication for blockbuster hopeful Livmarli
FDA has OK'd Mirum’s Livmarli to treat the rare liver disease PFIC. The nod comes on top of another for Livmarli to treat Alagille syndrome in 2021.
Kevin Dunleavy
Mar 13, 2024 6:20pm
Meet Madrigal, which wants to be your liver's No. 1 fan
Nov 15, 2023 9:40am
Salix teams with Bellamy Young to remove the stigma around HE
Oct 9, 2023 11:00am
Mirum ponies up $445M for 2 Travere liver disease drugs
Jul 18, 2023 8:00am
Intercept still has a long road ahead with Ocaliva in NASH
May 19, 2023 5:29pm
UK's NICE signs off on Gilead's hepatitis D drug
May 15, 2023 10:15am